Turkey
Oruba Health, founded in 2013 and headquartered in Turkey, is pioneering advancements in the Biotechnology, Digital Health, and Healthtech sectors. Their slogan, "Cleaner, faster & easier tests with operator-free medical devices," encapsulates their commitment to innovation.
The company’s flagship product, Oruflow, represents a breakthrough as the world’s first self-operating uroflowmeter. This device measures urine flow rate, providing crucial insights into lower urinary tract symptoms (LUTS), thus enabling important pre-screening health tests outside traditional clinical settings. This innovation aligns with global trends in decentralizing healthcare testing, particularly in urology.
Oruba Health’s interdisciplinary team—comprising experts in engineering, physics, industrial design, and urology—is focused on creating scalable technological solutions. Despite a strong foundation, the company is yet to secure its last investment, presenting a promising opportunity for investors to engage with a high-potential venture in the health and wellness domain.
